Mark O'Reilly currently serves as the Senior Business Development Director for Device & Diagnostic Solutions at Fortrea, where he leverages over a decade of experience in the Contract Research Organization (CRO) industry. His role is pivotal in supporting medical device clients as they navigate the...
Mark O'Reilly currently serves as the Senior Business Development Director for Device & Diagnostic Solutions at Fortrea, where he leverages over a decade of experience in the Contract Research Organization (CRO) industry. His role is pivotal in supporting medical device clients as they navigate the complexities of bringing innovative products to market across Europe, the United States, and the rest of the world. Mark's extensive expertise encompasses critical areas such as regulatory affairs, clinical studies, and health economics, allowing him to provide comprehensive support throughout the product lifecycle.
At Fortrea, Mark is deeply involved in key projects that focus on clinical investigations, post-market clinical follow-ups, and retrospective studies. His strategic approach to business development ensures that clients receive tailored solutions that address their unique challenges, from regulatory submissions to quality system enhancements. Mark's commitment to fostering long-standing partnerships is evident in his collaborative work with talented professionals in regulatory, clinical, toxicology, and health economics sectors.
His proficiency in global business development and proposal management, combined with a keen understanding of budget management, positions him as a trusted advisor for clients seeking to optimize their market entry strategies. Mark's passion for device consulting and reimbursement strategies further underscores his dedication to advancing the medical device industry, ensuring that innovative solutions not only meet regulatory standards but also achieve commercial success. Through his leadership at Fortrea, Mark continues to drive impactful change, helping clients realize their vision while navigating the intricate landscape of healthcare innovation.
